Evidence map›Paper›PMID 34139804›Full record

ArticleSingapore medical journal2022

Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore.

Zi Yun Chang, Paul Anantharajah Tambyah, Lionel Hon Wai Lum, Anantharaman Vathsala, Rachel Zui Chih Teo

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Singapore medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Zi Yun ChangDivision of Nephrology, National University Hospital, National University Health System, Singapore.
Paul Anantharajah TambyahDivision of Infectious Diseases, Department of Medicine, National University Hospital, National University Health System; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Lionel Hon Wai LumDivision of Infectious Diseases, Department of Medicine, National University Hospital, National University Health System; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Anantharaman VathsalaDivision of Nephrology, National University Hospital, National University Health System; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore; National University Centre for Organ Transplantation, National University Hospital, Singapore.
Rachel Zui Chih TeoDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore; National University Centre for Organ Transplantation, National University Hospital, Singapore.
National University Hospital · SGNational University Health System · SGNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Kidney TransplantationHumansImmunosuppression TherapyImmunosuppressive AgentsSARS-CoV-2SingaporeTransplant RecipientsImmunosuppressive Agents

Identifiers

PMID34139804
PMCPMC9875877
OpenAlexW3171292838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.